Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Wang Wang Jie M.D.
Peking University Cancer Hospital & Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the First Affiliated Hospital of Ustc Anhui Provincial Hospital
Hefei, Anhui, China
Not, yet, recruiting - Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting - Beijing Chest Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Not, yet, recruiting - Beijing Tiantan Hospital, Captal Medical University
Beijing, Beijing Municipality, China
Not, yet, recruiting - Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Recruiting - Pecking Union Medical College Hospital
Beijing, Beijing Municipality, China
Not, yet, recruiting - Peking University Third Hospital
Beijing, Beijing Municipality, China
Recruiting - Fujian Cancer Hospital
Fuzhou, Fujian, China
Not, yet, recruiting - the First Affiliated Hospital Xiamen University
Xiamen, Fujian, China
Not, yet, recruiting - the First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
Not, yet, recruiting - Zhujiang Hospital of Southem Medical University
Guangzhou, Guangdong, China
Not, yet, recruiting - Cancer Hospital Chinese Academy of Medical Sciences Shenzhen Center
Shenzhen, Guangdong, China
Not, yet, recruiting - Harbin Medical University Cancer Hospital-Mammary Gland of Internal
Harbin, Heilongjiang, China
Not, yet, recruiting - Henan Cancer Hospital
Zhengzhou, Henan, China
Not, yet, recruiting - the First Affiliated Hosipital of Zhengzhou University
Zhengzhou, Henan, China
Not, yet, recruiting - Renmin Hospital of Wuhan University
Wuhan, Hubei, China
Not, yet, recruiting - Tongji Hospital Tongji Medical College of Hust
Wuhan, Hubei, China
Not, yet, recruiting - Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
Not, yet, recruiting - Hunan Cancer Hospital
Changsha, Hunan, China
Not, yet, recruiting - Xiangya Hospital Central South Univesity
Changsha, Hunan, China
Not, yet, recruiting - the First Hospital of China Medical University
Shenyang, Liaoning, China
Not, yet, recruiting - the Affilated Hospital of Inner Mongolia Medical University
Hohhot, Neimenggu, China
Not, yet, recruiting - Qilu Hospital of Shandong University
Jinan, Shandong, China
Not, yet, recruiting - Shandong Cancer Hospital
Jinan, Shandong, China
Not, yet, recruiting - Linyi Cancer Hospital
Linyi, Shandong, China
Not, yet, recruiting - Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Not, yet, recruiting - the Second Affiliated Hospital Zhejiang School of Medicine
Hangzhou, Zhejiang, China
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Apr 2022
- Primary completion
- 31 Mar 2026
- Completion
- 31 Mar 2026
- Last update posted
- 4 Apr 2025
- Registered enrollment
- 240
- Registry id
- NCT05288205
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.